Yatin Suneja
Stock Analyst at Guggenheim
(4.86)
# 381
Out of 5,085 analysts
436
Total ratings
48.2%
Success rate
21.4%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Downgraded: Hold | n/a | $7.45 | - | 4 | Oct 26, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,185 → $1,120 | $875.76 | +27.89% | 27 | Oct 23, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $175 | $90.23 | +93.95% | 11 | Oct 20, 2026 | |
| EYPT EyePoint | Downgraded: Hold | n/a | $0.4281 | - | 10 | Oct 19, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $100 | $43.14 | +131.80% | 2 | Oct 12, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $20 | $3.53 | +466.57% | 8 | Oct 2, 2026 | |
| KRSA Korsana Biosciences | Initiated Coverage: Buy | $70 | $33.43 | +109.39% | 1 | Sep 28, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $100 | $28.97 | +245.18% | 11 | Sep 22, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | n/a | $3.80 | - | 10 | Sep 15, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $42 → $46 | $37.45 | +22.83% | 11 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.82 | - | 7 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $16.57 | +201.75% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $92.33 | +40.80% | 7 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $1.52 | +952.63% | 10 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $28.27 | +94.55% | 4 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $7.22 | +869.53% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $275 | $156.07 | +76.20% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $81.15 | +146.46% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $10.54 | +232.07% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $8.09 | +456.24% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $800 | $258.92 | +208.98% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $36.50 | +146.58% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $78.58 | +154.52% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,000 → $1,030 | $819.09 | +25.75% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $222 | $143.29 | +54.93% | 14 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $22 | $7.01 | +213.84% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $280 | $253.84 | +10.31% | 28 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $9.68 | +426.86% | 7 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $62 | $29.10 | +113.06% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.04 | +393.42% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.53 | +815.03% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.4057 | +3,350.83% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $25.70 | +133.46% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 → $100 | $4.28 | +2,236.45% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $48.10 | +191.06% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $12.34 | +62.07% | 11 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $2.27 | n/a | 11 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $20.31 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $25.75 | n/a | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.80 | n/a | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 2 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.29 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $17.43 | n/a | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.13 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $123 | $37.19 | n/a | 7 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $1.19 | n/a | 1 | Jul 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $32 | $13.14 | n/a | 4 | Dec 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $53.16 | n/a | 6 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.86 | n/a | 1 | Aug 13, 2014 |
Avalo Therapeutics
Oct 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.45
Upside: -
argenx SE
Oct 23, 2026
Reiterated: Buy
Price Target: $1,185 → $1,120
Current: $875.76
Upside: +27.89%
ABIVAX Société Anonyme
Oct 20, 2026
Reiterated: Buy
Price Target: $175
Current: $90.23
Upside: +93.95%
EyePoint
Oct 19, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4281
Upside: -
First Tracks Biotherapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $100
Current: $43.14
Upside: +131.80%
Zura Bio
Oct 2, 2026
Reiterated: Buy
Price Target: $20
Current: $3.53
Upside: +466.57%
Korsana Biosciences
Sep 28, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $33.43
Upside: +109.39%
Celldex Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $100
Current: $28.97
Upside: +245.18%
Sionna Therapeutics
Sep 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.80
Upside: -
Roivant Sciences
Sep 8, 2026
Reiterated: Buy
Price Target: $42 → $46
Current: $37.45
Upside: +22.83%
Sep 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.82
Upside: -
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $16.57
Upside: +201.75%
Aug 26, 2026
Reiterated: Buy
Price Target: $130
Current: $92.33
Upside: +40.80%
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $1.52
Upside: +952.63%
Aug 13, 2026
Reiterated: Buy
Price Target: $55
Current: $28.27
Upside: +94.55%
Aug 11, 2026
Reiterated: Buy
Price Target: $70
Current: $7.22
Upside: +869.53%
Aug 10, 2026
Reiterated: Buy
Price Target: $260 → $275
Current: $156.07
Upside: +76.20%
Aug 10, 2026
Reiterated: Buy
Price Target: $200
Current: $81.15
Upside: +146.46%
Aug 7, 2026
Reiterated: Buy
Price Target: $35
Current: $10.54
Upside: +232.07%
Aug 6, 2026
Reiterated: Buy
Price Target: $45
Current: $8.09
Upside: +456.24%
Aug 6, 2026
Reiterated: Buy
Price Target: $800
Current: $258.92
Upside: +208.98%
Aug 6, 2026
Reiterated: Buy
Price Target: $90
Current: $36.50
Upside: +146.58%
Aug 5, 2026
Reiterated: Buy
Price Target: $200
Current: $78.58
Upside: +154.52%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,000 → $1,030
Current: $819.09
Upside: +25.75%
Jul 31, 2026
Reiterated: Buy
Price Target: $200 → $222
Current: $143.29
Upside: +54.93%
Jul 31, 2026
Reiterated: Buy
Price Target: $25 → $22
Current: $7.01
Upside: +213.84%
Jul 21, 2026
Rated: Buy
Price Target: $260 → $280
Current: $253.84
Upside: +10.31%
Jul 17, 2026
Reiterated: Buy
Price Target: $51
Current: $9.68
Upside: +426.86%
May 26, 2026
Reiterated: Buy
Price Target: $44 → $62
Current: $29.10
Upside: +113.06%
May 13, 2026
Reiterated: Buy
Price Target: $15
Current: $3.04
Upside: +393.42%
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $1.53
Upside: +815.03%
May 7, 2026
Reiterated: Buy
Price Target: $14
Current: $0.4057
Upside: +3,350.83%
May 7, 2026
Reiterated: Buy
Price Target: $60
Current: $25.70
Upside: +133.46%
Mar 13, 2026
Reiterated: Buy
Price Target: $128 → $100
Current: $4.28
Upside: +2,236.45%
Mar 4, 2026
Reiterated: Buy
Price Target: $140
Current: $48.10
Upside: +191.06%
Feb 24, 2026
Reiterated: Buy
Price Target: $20
Current: $12.34
Upside: +62.07%
Sep 29, 2025
Reiterated: Buy
Price Target: $26
Current: $2.27
Upside: n/a
Feb 27, 2025
Reiterated: Hold
Price Target: $20
Current: $20.31
Upside: n/a
Jan 3, 2025
Upgraded: Buy
Price Target: $45
Current: $25.75
Upside: n/a
Dec 11, 2024
Downgraded: Hold
Price Target: n/a
Current: $8.80
Upside: n/a
Sep 21, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $3.29
Upside: n/a
May 31, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $17.43
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $9
Current: $1.13
Upside: n/a
Jul 20, 2018
Reiterated: Buy
Price Target: $115 → $123
Current: $37.19
Upside: n/a
Jul 13, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $1.19
Upside: n/a
Dec 12, 2017
Reiterated: Buy
Price Target: $21 → $32
Current: $13.14
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: n/a
Current: $53.16
Upside: n/a
Aug 13, 2014
Reiterated: Buy
Price Target: n/a
Current: $16.86
Upside: n/a